Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for VOX.WA and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for VOX.WA and 80,000+ other tickers.
See exactly how VOX.WA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for VOX.WA and 80,000+ other tickers.
Voxel S.A. manages an extensive chain of facilities dedicated to diagnostic medical imaging. The company's offerings encompass a broad range of advanced imaging services, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and single photon emission computed tomography (SPECT). Furthermore, Voxel S.A. provides teleradiology and outsourcing solutions within the diagnostic imaging sector, alongside developing information systems specifically designed for hospitals and diagnostic centers. The firm also undertakes ventures focused on equipping…
No recent news available.